Emin Çakiroğlu, A. Annakkaya, Kezban Özmen Süner, Ümran TORU ERBAY
{"title":"Obstrüktif Uyku Apnede (OUA) Ortalama Trombosit Hacmi (OTH) ve OUA'da Sürekli Pozitif Hava Yolu Basıncı (CPAP) Tedavisinin OTH Üzerine Etkisi","authors":"Emin Çakiroğlu, A. Annakkaya, Kezban Özmen Süner, Ümran TORU ERBAY","doi":"10.18521/ktd.1350048","DOIUrl":null,"url":null,"abstract":"Aims: In this study, our objective was to evaluate mean platelet volume (MPV), an indirect marker of platelet activation, in patients with obstructive sleep apnea (OSA), and assess the effect of OSA treatment with continuous positive airway pressure (CPAP) on MPV Methods: In this study, records of consecutive patients who underwent polysomnographic evaluation for OSA symptoms in the Sleep Disorders Laboratory during a one-year period were reviewed retrospectively. Patients who had both complete blood count and MPV measurements were included in the study. Results: A total of 158 patients, including 51 females (32.3%) and 107 males (67.7%), were included in the study. The mean age of the patients was 51±13 (min-18, max-82) years. OSA was detected in 74.1% (117/158) of the patients. It was determined that as the severity of OSA increased, hemoglobin and hematocrit values increased significantly. There was no significant difference in platelet count according to the presence and severity of OSA. The MPV was significantly lower in severe OSA cases compared to those without OSA and mild OSA cases. A negative correlation was observed between MPV and the apnea-hypopnea index, desaturation index, and the amount of oxygen saturation below 90% during sleep. There was no significant difference in median erythrocyte and thrombocyte counts, hematocrit percentage and hemoglobin values before and after treatment in OSA patients who used CPAP therapy. However, a significant decrease in MPV was observed after OSA treatment compared to pre-treatment. (p=0.021). Conclusions: The results of the study do not support an increase in MPV and hence platelet activation in severe OSA patients compared with those without OSA. However, the results suggest that one month of CPAP treatment reduces MPV and thus platelet activation in severe OSA patients. Further controlled, prospective studies including treatment outcomes are needed on this subject.","PeriodicalId":17884,"journal":{"name":"Konuralp Tip Dergisi","volume":"64 12","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Konuralp Tip Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18521/ktd.1350048","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: In this study, our objective was to evaluate mean platelet volume (MPV), an indirect marker of platelet activation, in patients with obstructive sleep apnea (OSA), and assess the effect of OSA treatment with continuous positive airway pressure (CPAP) on MPV Methods: In this study, records of consecutive patients who underwent polysomnographic evaluation for OSA symptoms in the Sleep Disorders Laboratory during a one-year period were reviewed retrospectively. Patients who had both complete blood count and MPV measurements were included in the study. Results: A total of 158 patients, including 51 females (32.3%) and 107 males (67.7%), were included in the study. The mean age of the patients was 51±13 (min-18, max-82) years. OSA was detected in 74.1% (117/158) of the patients. It was determined that as the severity of OSA increased, hemoglobin and hematocrit values increased significantly. There was no significant difference in platelet count according to the presence and severity of OSA. The MPV was significantly lower in severe OSA cases compared to those without OSA and mild OSA cases. A negative correlation was observed between MPV and the apnea-hypopnea index, desaturation index, and the amount of oxygen saturation below 90% during sleep. There was no significant difference in median erythrocyte and thrombocyte counts, hematocrit percentage and hemoglobin values before and after treatment in OSA patients who used CPAP therapy. However, a significant decrease in MPV was observed after OSA treatment compared to pre-treatment. (p=0.021). Conclusions: The results of the study do not support an increase in MPV and hence platelet activation in severe OSA patients compared with those without OSA. However, the results suggest that one month of CPAP treatment reduces MPV and thus platelet activation in severe OSA patients. Further controlled, prospective studies including treatment outcomes are needed on this subject.
阻塞性睡眠呼吸暂停(OSA)患者的平均血小板体积(MPV)以及持续气道正压(CPAP)治疗对 OSA 患者平均血小板体积的影响
目的:本研究旨在评估阻塞性睡眠呼吸暂停(OSA)患者的平均血小板体积(MPV)(血小板活化的间接标志),并评估使用持续气道正压(CPAP)治疗 OSA 对 MPV 的影响:在这项研究中,我们回顾性审查了一年内因 OSA 症状在睡眠障碍实验室接受多导睡眠图评估的连续患者的记录。同时进行全血细胞计数和脉压测量的患者均被纳入研究范围。 研究结果共有 158 名患者参与了研究,其中包括 51 名女性(32.3%)和 107 名男性(67.7%)。患者的平均年龄为 51±13 岁(最小-18 岁,最大-82 岁)。74.1%的患者(117/158)被检测出患有 OSA。研究结果表明,随着 OSA 严重程度的增加,血红蛋白和血细胞比容值也明显增加。血小板计数在 OSA 的存在和严重程度上没有明显差异。与无 OSA 和轻度 OSA 病例相比,重度 OSA 病例的 MPV 明显较低。MPV 与呼吸暂停-低通气指数、失饱和度指数以及睡眠中氧饱和度低于 90% 的数量之间呈负相关。使用 CPAP 治疗的 OSA 患者的红细胞和血小板计数中位数、血细胞比容百分比和血红蛋白值在治疗前后无明显差异。然而,与治疗前相比,OSA 治疗后观察到 MPV 明显下降。(p=0.021). 结论:与没有 OSA 的患者相比,研究结果不支持严重 OSA 患者的 MPV 增加,从而导致血小板活化。然而,研究结果表明,CPAP 治疗一个月可降低 MPV,从而降低严重 OSA 患者的血小板活化。关于这个问题,还需要进一步开展包括治疗结果在内的前瞻性对照研究。